RESEARCH, PHARMACY MARKET

Best practices in viral vector analytical characterization

December 13, 2022

Best practices in viral
Viral vectors are a critical part of the advanced therapies
supply chain as they are used to introduce the gene of
interest, whether that’s into a cell intended for therapeutic
gene transfer or for direct viral-mediated gene transfer into
the patient.

Spotlight

Dauntless Pharmaceuticals, Inc

Dauntless Pharmaceuticals, Inc., is a biopharmaceutical company focused on the development of specialty drugs. Our innovative one-asset, one-company model facilitates operational efficiency, drug development speed, and a simplified business development structure, leading to lower costs, shorter timelines and higher returns.

OTHER WHITEPAPERS
news image

QbD and PAT in Biopharmaceutical Development

whitePaper | July 12, 2022

As the pharmaceutical industry tries to embrace the methodologies of quality by design (QbD) provided by the FDA ’s process validation (PV) guidance (1) and International Conference on Harmonization.

Read More
news image

Characterization of Protein Aggregates and Other Particles in Biopharmaceuticals

whitePaper | July 8, 2022

Particulates are ubiquitous in parenteral drug products and remain a concern throughout their development and production1–3. These particles must be monitored to satisfy.

Read More
news image

Blockchain technology in the pharmaceutical industry

whitePaper | March 11, 2022

Blockchain technology is accelerating digital transformation across multiple industries, including the pharmaceutical industry.

Read More
news image

How to optimize clinical supply chain management with Slope

whitePaper | December 15, 2022

Successful execution of clinical trials requires the orchestration of multiple moving parts, with everything from protocol design and patient visit schedules, to lab kits and biological samples needing to seamlessly line up to ensure on-time, on-budget delivery of high-quality data.

Read More
news image

Understanding the true cost of transparency reporting

whitePaper | December 14, 2022

When the regulatory hammer came down on pharmaceutical and life sciences (PLS) companies in the 2010s, it introduced new complexities for these businesses.

Read More
news image

Expediting early-phasedevelopment ofsmall molecules: Anintegrated approach

whitePaper | November 18, 2022

Small molecule drug development has changed substantially in recent years. With the heightened focus on molecularly targeted therapies, small molecule active pharmaceutical ingredients (APIs).

Read More

Spotlight

Dauntless Pharmaceuticals, Inc

Dauntless Pharmaceuticals, Inc., is a biopharmaceutical company focused on the development of specialty drugs. Our innovative one-asset, one-company model facilitates operational efficiency, drug development speed, and a simplified business development structure, leading to lower costs, shorter timelines and higher returns.

Events